Health Condition 1: null- patients undergoing urethroplasty.
Conditions
Interventions
Intervention1: Group RD: Intravenous dexmedetomidine 1 mcg/kg in 10ml NS over 10 minutes and caudal block with 0.75ml/kg of 0.25% ropivacaine.
Control Intervention1: Group RS
: Intravenous 10 ml of NS
Sponsors
AIIMS
Eligibility
Inclusion criteria
Inclusion criteria: ASA I-II Age 2- 8 yrs Undergoing urethroplasty
Exclusion criteria
Exclusion criteria: Parental or guardian refusal Hypersensitivity to any local anaesthetic Bleeding diathesis Infection at puncture site Children with uncorrected heart disease Children with heart block or liver impairment Preexisting neurological diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of intravenous dexmedetomidine on caudal analgesia , to compare the time to rescue analgesia.Timepoint: The duration of analgesia is from the time of caudal injection to the time of FLACC score 4. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the incidence of emergence agitation To compare the time for discharge based on modified aldrete score. To compare the postoperative sedation. Timepoint: Sedation score will be assessed using Modified Ramsayâ??s sedation score Time taken to achieve Aldrete score of 9 will be noted. | — |
Countries
India
Contacts
Public ContactTanya Aysha Edathodu
AIIMS, New delhi.
Outcome results
None listed